NEW YORK (GenomeWeb) – Courtagen Life Sciences reported today that it has completed the comprehensive Clinical Laboratory Evaluation Program and has received its clinical laboratory permit form the state of New York.

Courtagen — a CLIA/CAP certified company — creates tests for the diagnosis of neurological disorders, primarily using next-generation DNA sequencing, bioinformatics, and clinical interpretation. These tests are designed to help physicians reveal the linkages between the genotypes and phenotypes of various neurological diseases, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.